POINT BIOPHARMA GLOBAL INC. Accumulated Other Comprehensive Income
POINT BIOPHARMA GLOBAL INC. had Accumulated Other Comprehensive Income of -$1.43 million as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2023-11-13
- 2023-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.43M.
- 2023-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.07M.
- 2023-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$255.56K.
- 2022-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$456.85K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2023-09-30 | -$1.43M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$1.07M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$255.56K 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$456.85K 10-Q · filed 2023-11-13 |
| 2022-09-30 | -$608.70K 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$342.38K 10-Q · filed 2022-08-12 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-27 |